electroCore Expands Manufacturing Capabilities for gammaCore™
27 Novembro 2018 - 11:00AM
electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a
commercial-stage bioelectronic medicine company, today announced
expansion into a new design and development facility to support
increasing patient demand of its gammaCore™ non-invasive vagus
nerve stimulator product.
“We are pleased to announce expansion into this new design,
development and manufacturing facility which will ensure we can
meet growing patient demand for gammaCore,” said Frank Amato, Chief
Executive Officer of electroCore. “We look forward to enhancing and
expanding our operational efficiency with modern capabilities to
streamline prototyping and broader manufacturing and distribution
resources.”
The 13,640-square-foot office and manufacturing facility is
located at Forge Way Business Center in Rockaway, New Jersey. The
Company plans to take occupancy in the first quarter of 2019.
electroCore, Inc. was founded in 2005 with the mission to help
patients worldwide who suffer from pain and chronic conditions. The
company’s first product, gammaCore, was cleared by the United
States Food and Drug Administration for the acute treatment of pain
associated with episodic cluster headache in April 2017 and for the
acute treatment of pain associated with migraine in January 2018.
The next generation of gammaCore, gammaCore Sapphire, was launched
in August 2018 with improved design features for ease and comfort
during patient use.
About electroCore, Inc.electroCore, Inc. is a
commercial-stage bioelectronic medicine company dedicated to
improving patient outcomes through its platform non-invasive vagus
nerve stimulation therapy initially focused on the treatment of
multiple conditions in neurology and rheumatology. The Company’s
initial targets are the acute treatment of migraine and episodic
cluster headache.
For more information, visit www.electrocore.com.
ContactsInvestors: Greg
Chodaczek or Lynn Lewis Gilmartin Group
investors@electrocore.com (646) 924-1769
or
Media: Alexandra Canale GCI Health (617)
921-9353 alexandra.canale@gcihealth.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024